Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)

NCT03091400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Memory Disorders
Multiple Sclerosis

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai